Nitric oxide: Concepts, current perspectives and future therapeutic implications

Indian Journal of Pharmacology

Volumn 30, Issue 6, 1998, Pages 351-366

  Chandran, Sajeev ^a   Sridhar, N ^a   Veeranjaneyulu, Addepalli ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Nitric oxide; Nitric oxide synthase; NO donors; NOS inhibitors

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

EFFECTOR CELL; ELECTRON TRANSPORT; ENZYME SYNTHESIS; GLYCOLYSIS; MEDIATOR RELEASE; MITOCHONDRIAL RESPIRATION; MUTAGENESIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; REVIEW; TARGET CELL; TRANSCRIPTION REGULATION;

EID: 0032433862     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, Pathophysiology and Pharmacology. Pharm Rev 1991; 42(2):109-42.
2. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
3. Anggard E. Nitric oxide: mediator, murderer and medicine. Lancet 1994;343:1199-206.
4. Madison DV. Pass the nitric oxide. Proc Natl Acad Sci , USA 1993;90:4329-31.
5. Kimura H, Mittal CK, Murad F. Activation of guanylate cyclase from liver and other tissues by sodium azide. J Biol Chem 1975;250:8016-22.
6. Mittal CK, Kimura H, Murad F. Requirement of a macromolecular factor for sodium azide activation factor for guanylate cyclase. J Cyclic Nucleotide Res 1975;1: 261-9.
7. Mittal CK, Kimura H, Murad F. Purification and properties of a protein factor required for sodium azide activation of guanylate cyclase. J Biol Chem 1977;252:4384-90.
8. Arnold WR Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases cGMP levels in various tissues. Proc Natl Acad Sci, USA 1977;74:3203-7.
9. Mittal GK, Murad F. Activation of guanylate cyclase by super oxide dismustase and hydroxyl radical - a physiological regulator of guanosine - 3′, 5′ monophosphate formation. Proc.Natl Acad Sci 1977;74:4360-4.
10. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, et al. Mechanism of vascular smooth relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:33-42.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
12. Needleman P, Hunter FE. Organic nitrate metabolism. Annu Rev Pharmacol Toxicol 1976;16:81-93.
13. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987;327:524-6.
14. Palmer RMJ, Rees DD, Ashton DS, Monacada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium dependent relaxation. Biochem Biophys Res Comm 1988;153:1251-6.
15. Mittal CK. Nitric oxide synthase : Involvement of oxygen radicals in conversion of L-arginine to nitric oxide. Biochem Biophys Res Commun 1993;193:126-32.
16. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium derived relaxing factors : cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci,USA 1990;87:8612-6.
17. Drexler H, Zeiher AM, Meinzer K. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;338: 1546-50.
18. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide, a physiologic messenger. Ann Intern Med 1994;120:227-37.
19. Nathan C, Xie QW. Nitric oxide syntheses; Roles, Tolls and Controls. Cell 1994;78: 915-8.
20. Mittal CK. Oxygen radicals/ NO mediate calcium dependent actions of hormones on cyclic GMP system : A novel concept in signal transduction. Mol Cell Biochem 1995; 149/ 150:257-62.
21. Mittal CK, Mehta CS. Regulation of nitric oxide synthase : Role of oxygen radicals and cations in nitric oxide formation. Adv in Pharmacol 1995;34:235-50.
22. Buscona L, Michel T. Endothelial nitric oxide synthase; N-terminal determines subcellular localization. J Biol Chem 1993;268:8410-13.
23. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci 1993;90:6252-6.
24. Sessa WC, Pitchard K, Seyedi N, Wang J, Hintze TH. Chronic exercise in dog increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-53.
25. Furchgott RF, Vanhoutte PM. Endothelium derived relaxing and contractor factors. FASEB J 1989;3:2007-18.
26. Ignarro LJ. Endothelium derived nitric oxide: actions and properties. FASEB J 1989;3:31-6.
27. Moncada S, Higgs A. The L-arginine -nitric oxide pathway. N Eng J Med 1993;329: 2002-12.
28. Calver H, Collier J, Vallance P. Nitric oxide and cardiovascular control. Exp Physiol 1993;78:303-26.
29. Misko TP, Moore WM, Kasten TP , et al. Selective inhibition of inducible nitric oxide synthase by amino guanidine. Eur J Pharmacol 1993;233:119-25.
30. Synder SH, Nitric oxide : The first new class of neurotransmitters. Science 1992;54:171-8.
31. Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterisation of molecular targets for NO in mammalian cells and organelles. FASEB J 1993; 1:1123-4.
32. Stamler JS, Simon DI, Osbourne JA, et al. S-nitrosylation of protiens with nitric oxide: synthesis and characterisation of biologically active compounds. Proc Natl Acad Sci 1992;89:444-8.
33. Stamler JS, Jaraki O, Osbourne JA, et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sc 1992;89: 7674-7.
34. Benjamin N, O'Driscoll F, Dougall H, Smith L, Golden N. Stomach NO synthesis. Nature 1994;368:502-4.
35. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
36. Henderson AH. Endothelium in control. Br Heart J 1991; 65:116-25.
37. Ribairo MO, Antanes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A model of arterial hypertension. Hypertension 1992;20:298-303.
38. Rees DD, Palmer RM, Moncada S. Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 1989;86:3375-8.
39. Yukimura T, Yamashita Y, Miura K, Okumura M, Yamanaka S, Yamamoia K. Renal effects of the nitric oxide synthase inhibitor L-NG-nitro arginine in dogs. Am J Hypertension 1992;5:484-7.
40. Vallance P, Collier J, Moncada S. Effect of endothelium derived nitric oxide on peripheral arterial tone in man. Lancet 1989;2:997-1000.
41. Schror K, Woditsch I, Strobach H, Schroder H. Interactions between nitric oxide and prostacyclin in myocardial ischemia and endothelial cell cultures. Basic Res Cardiol 1991;86(suppl 2):117-25.
42. Matheis G, Sherman MP, Buckberg GD, Hayborn DM, Young HH, Ignarro IJ, Role of L-arginine - nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262:H616-20.
43. Carey C, Siegfried MR, Ma XL, Weyrich AS, Lefer AM. Antishock NO donor in mesentric ischemia and reperfusion. Cir Shock 1992;38:209-16.
44. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophils adherence to coronary endothelium. Circ Res 1993;72:403-12.
45. Buga GM, Gold MF, Fukuto JM, Ignarro IJ. Shear stress induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991;17:187-93.
46. Kelm M, Feelisch M, Deussen A, Strauss BE, Schrader J. Release of endothelium derived nitric oxide in relation to pressure and flow. Cardiovasc Res 1991;25:831-6.
47. Ueeda M, Silivia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res 1992; 70:1296-303.
48. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 1992;70:123-30.
49. Pohl U, Herian K, Huang A, Bassenge E. EDRF mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol 1991; 261:H2016-23.
50. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilatory response to increased flow in-vivo. Hypertension 1986;8:37-44.
51. Faraci FM, Breesse KR. Nitric oxide mediates vasodilation in response to activation of N-methyl-D-aspatrate receptors in brain. Circ Res 1993;72:476-80.
52. Tanaka K, Gotoh F, Gomi S, Takashima S, Mihara B, Shiral et al. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci Lett 1991;127:129-32.
53. Toda N, Okamura T. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am J Physiol 1990;259:H1511-7.
54. Broton TR Miyashiro JK, Moncada S, Feigi EO. Role of endothelium derived relaxing factor in parasympathetic coronary vasodilation. Am J Physiol 1992;262:H1579-84.
55. Richard V, Berdeaux A, La Rochelle CD, Gludicell JF. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetised open chest dogs. Br J Pharmacol 1991;104:59-64.
56. Benyo Z, Kiss G, Szabo C, Csaki C, Kovach AG. Importance of basal nitric oxide synthesis in regulation of myocardial blood flow. Cardiovasc Res 1991;25:700-3.
57. Jone LF, Brody MJ. Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J Pharmacol ExpTher 1992;260:627-31.
58. Fineman JR, Heymann MA, Solfer SJ, N-omega-nitro-L-arginine attenuates endothelium dependent pulmonary vasodilation in lambs. Am J Phsyiol 1991;260:H1299-306.
59. Iwata F, Job T, Kawai T, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol 1992;263;G149-54.
60. Deng A, Bayllis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 1993:264:F212-5.
61. Nozald K, Maskourtz MA, Mnynard KI, et al. Possible origins and distribution of immunoreactive nitric oxide synthase containing nerves fibres in cerebral arteries. J Cereb Blood Flow Metab 1993;13:70-9.
62. Panza JA, Quyyumi AA, Brush JF Jr., Epstein SE. Abnormal endothelium dependent vascular endothelium vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
63. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium derived relaxing factor in human forearm circulation in-vivo. Blunted response in essential hypertension. Circulation. 1990;81:1762-7.
64. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium derived nitric oxide in the abnormal endothelium dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-74.
65. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension : the nitric oxide dilator mechanism appears abnormal. J Hypertension 1992;19:326-32.
66. Faraci FM, Heistad DD. Endothelium derived relaxing factor inhibits constrictor responses of large cerebral arteries to serotonin. J Cereb Blood Flow Metab 1992;12:500-6.
67. Flavahan NA. Atherosclerosis or lipoprotein induced endothelial dysfunction; potential mechanisms underlying the reduction in EDRF/ NO activity. Circulation. 1992;85:1927-38.
68. Sieber CC, Lopez-Talavera JG, Groszmann RJ. Role of nitric oxide in the in-vitro splanchic vascular hyporeactivity in ascitic cirhotic rats. Gasteroenterology 1993104:1750-4.
69. Castro A, Jimenez W, Claria J, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993;18:367-72.
70. Sogni P, Moreau R, Oshuga M, et al. Evidences for normal nitric oxide mediated vasodialator tone in concious rats with cirrhosis. Hepatology 1992;16:980-3.
71. Pizcueta P, Pique JM, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gasteroenterology 1992;103:1909-15.
72. Thiemermann C, Szabo C, Mitchell JA, Vane JR. Vascular hyporeactivity to vasoconstrictor agents and haemodynamic decomposition in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci 1993;90:267-71.
73. Nava E, Palmer RM, Moncada S. Inhibition of NO synthesis in septic shock : How much is beneficial ? Lancet 1991; 338:776-8.
74. Radomski MW, Palmer RM, Moncada S. Characterisation of the L-arginine nitric oxide pathway in human platelets. Br J Pharmacol 1990;101:325-8.
75. Radomski MW, Palmer RM, Moncada S. An L-arginine/ nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci 1990;87:5193-7.
76. Varela AF, Runge A, Ignarro IJ, Chaudhuri G. Nitric oxide and prostacyclin inhibit fetal platelet aggregation a response similar to that observed in adults. Am J Obstet Gynecol 1992;167:1599-604.
77. 2+ and on aggregation of human platelets Eur J Pharmacol 1993;244:37-47.
78. Vallance P, Benjamin N, Collier J. The effect of endothelium derived nitric oxide on ex-vivo whole blood platelets aggregation in man. Eur J Clin Pharmacol 1992;42:37-41.
79. Radomski MW, Palmer RM, Moncada S. The ana-aggregating properties of vascular endothelium; interaction between prostacyclin and nitric oxide. Br J Pharmacol 1987; 92:639-46.
80. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
81. Radomski MW, Palmer RM, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Ras Commun 1987;148:1482-9.
82. Siney L, Lewis MJ. Endothelium derived relaxing factor inhibits platelet adhesion to cultured porcine endocardial endothelium. Eur J Pharmacol 1992;229:223-6.
83. Nolte C, Eigenthaler M, Schanzenbacher P, Walter U. Endothelial cell dependent phosphorylation of a platelet protein mediated by cAMP and cGMP elevation factors. J Biol Chem 1991;266:14808-12.
84. 1. J Cardiovasc Pharmacol 1991;17:424-428.
85. Brune B, Molina Y, Vedia L Lapetina EG. Agonist induced ADP-ribosylation of a cytosolic protein in human platelets. Proc Natl Acad Sci 1990;87:3304-8.
86. Durante W, Kroll MH, Vanhoutte PM, Schafer AL, Endotheiium derived relaxing factor inhibits thrombin induced platelet aggregation by inhibiting platelet phospholipase-C. Blood 1992;79:110-6.
87. Park KGM, Haynes PD, Gartick PJ Sewell H, Eremin O. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991;337:1546-50.
88. Taylor RL Jr., Auste RE, Dietert RR. Dietary arginine influences Rous sarcoma growth in a major histocompatibility P complex progressor genotype. Proc Soc Exp Biol Med 1992;199:38-41.
89. Das UN. L-arginine, nitric oxide and collagen vascular diseases. A potential relationship. Nutrition 1992;8:371-5.
90. Barnes PJ. Nitric oxide and airways. Eur Resp J 1993;6:163-5.
91. Sprague R, Thiemerman C Vane JR. Endogenous endothelium derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc Natl Acad Sci 1992;89:8711-5.
92. Frostell CG, Fratacci MD, Wain JC, Zapol WM. Inhaled nitric oxide : a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83: 2038-47.
93. Pepke-Zabe J, Higenbottam TW, Dinh-Zuan AT, Stone D, Wallwork J. Inhaled nitric oxide causes selective pulmonary vasodilation in patients with pulmonary hypertension. Lancet 1991;338:1173-4.
94. Rossiant R, Falke KS, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engt J Med 1993;328:399-405.
95. Persson MG, Zetterstrom O, Agrenius V, Ihre E, Gustafsson LE. Single breath measurements of nitric oxide : increased concentration in asthamatics and reduction in smokers. Lancet 1994;343:146-7.
96. Kharitonov SA, Yates D, Bobbins RA, Logam-Sinclair, Shinebroune EA, Barnes PJ Endogenous nitric oxide is increased in exhaled air of asthamatic patients. Lancet 1994;343:133-5.
97. Bredt DS, Hwang PM, Snyder SH. Localisation of nitric oxide synthase indicating a neural role for nitric oxide. Nature 1990;347:768-70.
98. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 1994;263:687-9.
99. Zorumski CF, Igumi Y. Nitric oxide and hippocampal synaptic plasticity. Biochem Pharmacol 1993;46:777-85.
100. Maagos CM, Wang JM, Hrabie JA, Oppenhium JJ, Keefer LK. Nitric oxide/nucleophile complexes inhibit the in-vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 1993;53:564-8.
101. Li L, Kilbourn RG, Admans J, Fidler IJ. Role of nitric oxide in lysis of tumor cell by cytokine activated endothelial cells. Cancer Res 1991;51:2531-5.
102. Ye S-L, Istfan NW, Driscoll DF, Bistrian BR. Tumor and host response to arginine and branched chain amino acid enriched total parenteral nutrition. Cancer 1992;69:261-70.
103. Park KGM, Heys SD, Harris I et al. Arginine metabolism in benign and malignant disease of breast and colon. Evidence of possible inhibition of tumor infiltrating macrophages. Nutrition 1991;7:185-8.
104. Wink DA, Kasprazak KS, Maragos CM, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitor. Science 1991;254:1001-3.
105. Kwon NS, Stuchr DJ, Nathan CF. Inhibition of tumor cell ribonucleoside reductase by macrophage derived nitric oxide. J Exp Med 1991;174:761-7.
106. Lukic ML , Grujicic SS, Ostojic N, Chan WL, Liew FY. Inhibition of nitric oxide generation affects the induction of diabetes by streptomycin in mice. Biochem Biophys Res Commun 1991;178:913-20.
107. Schmidt HHW, Warner TD, Ishii K, Sheng H, Murad F. Insulin secretion from pancreatic β -cells caused by L-arginine derived nitric oxides. Science 1992;255:721-3.
108. Rand MJ. NANC transmission of nitric oxide as mediator of non-adrenergic non- cholinergic neuro effector transmission. Clin Exp Pharmacol Physiol 1992;19:147-9.
109. Sanders KM, Ward SM. Nitric oxide as mediator of non-adrenergic non-cholinergic transmission. Am J Physiol 1992;262:G379-92.
110. Franks CM, Hardcastle J, Hardcastle PT. Involvement of nitric oxide in the response of 5-HT in rat in-vivo. J Pharm Phamacol 1994;46:387-9.
111. Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accomadate food or fluid. Nature 1991;351:477-9.
112. Tattrup A, Glavid EB, Svane D. Involvement of L-arginine-NO pathway in internal anal sphincter relaxation. Gasteroenterology 1992;102:409-15.
113. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH. Nitric oxide a physiological mediator of penile errection. Science 1992;257:401-3.
114. Raifer J, Aronson WJ, Bush PA, Doren FS, Ignarro LJ. Nitric oxide as a mediator of relaxation of corpus cavernosum in response to NANC neurotransmission. N Engl J Med 1992;326:90-4.
115. Feelish M, Ostrowski J, Noack E. On the mechanism of NO release from sydnomines. J Cardiovasc Pharmacol 1989;14(suppl11):S13-22.
116. Bohn H, Martorana PA, Schonalinger K. Cardiovascular effects of the new nitric oxide donor pirsidomine. Haemodynamic profile and tolerance studies in anesthetised and conscious dogs. Eur J Pharmacol 1992;220:71-78.
117. Lefer DJ, Nakanishi K, johnston WE, Vinten Johansen J. Anti-neutrophil and myocardial protecting actions of novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993;88:2337-50.
118. Mortey D, Maragos CM, Zhang XY, Boignon M, Wink DA, Keefer LK. Mechanism of vascular relaxation induced by the nitric oxide/ nucleophile complexes; a new class of NO-based vasodilators, J Cardiovasc Pharmacol 1993;21:670-6.
119. Wolff DJ, Gribin BJ. The inhibition of constitutive and inducible nitric oxide synthase isoforms by indazole agents. Arch Biochem Biophys 1994;311:300-6.
120. Garvey EP, Oplinger JA, Tanoury GJ, et al. Potent and selective inhibitors of human nitric oxide syntheses. J Biol Chem 1994;269:26669-76.
121. Nakane M, Klinghofer V, Kuk J, et al. Novel potent and selective inhibitors of inducibie nitric oxide synthase. Mol Pharmacol 1995;47:831-4.
122. Rees DD, Palmer RMJ, Schulz R, et al. Characterization of three inhibitors of endothelial nitric oxide synthase invitro and invivo. Br J Pharmacol 1990;101:746-52.
123. Furfine ES, Harmon MF, Paith JE, Garvey EP. Selective inhibition of constitutive nitric oxide synthase by NG-nitro arginine. Biochemistry 1993;32:8512-17.
124. Knowles RG, Moncada S. Nitric oxide synthases in mammals, Biochem J 1994;298:249-58.
125. Moore WM, Handy S. Selective inhibitors of neuronal nitric oxide synthase - Is NOS really good NOS for the nervous system? Tips 1997;18:204-6.
126. Manisha I. Viagra : The first oral treatment for impotence. Pharm J 1998;261:164-5.
127. Kerwin JF, Heller M. The arginine nitric oxide pathway ; a target for new drugs. Med Res Rev 1993;14:23-74.
128. Curtis MJ, Pabla R. Nitric oxide supplementation or synthesis block which is better approach to treatment of heart disease. TIPS 1997;18:239-44.